Invus

1985

Founded

163

Investments

United States

Offices

Venture Fund

Investor Type

About

Invus is an evergreen equity investment firm founded in 1985, managing over $10 billion in capital. With offices in New York, Paris, and Hong Kong, Invus focuses on empowering owner-managers to transform their industries by providing the freedom to take risks, the capital to reach their goals, and the strategic advice to navigate uncharted waters. The firm emphasizes a long-term investment horizon, aiming for exponential, sustainable value creation through building sustainable competitive advantages and innovating to fulfill real customer needs.

Invus operates with a unique structure that allows flexibility in the types of companies and situations they engage with, fully aligning their incentives with their partners and demonstrating a long-term commitment to see through any challenges along the way. Since its inception, Invus has been successfully empowering owner-managers, with its source of capital being a European family group through their Artal investment vehicle. This evergreen structure has enabled Invus to compound its initial pool of capital over four decades, growing to over $10 billion even after distributing billions to shareholders.

Portfolio Companies

Achilles Therapeutics, Sensorion, KNIME, Artal Group, Action Against Hunger, Paya Lebar Quarter 1, Paya Lebar Link, Paya Lebar Quarter 1, Paya Lebar Link, Paya Lebar Quarter 1

Gepgraphic Focus

North America, Europe, Asia

Key Differentiators

Evergreen investment structure, Long-term investment horizon, Alignment with owner-managers

Thypical Investment Size

Varies based on opportunity

Total Funds Raised

Over $10 billion

Visit Website

BioTech

Artificial Intelligence & Machine Learning (AI/ML)

FinTech

Food and Beverage

New York

Pre-Seed

Seed

Series A

Series B

Series C

Series D

United States